Rapid communication · 29 May 2025
Conference abstractPublished 2016
Glucose homeostasis after simultaneous pancreas and kidney transplantation: A comparison of subjects with C-peptide positive non-type 1 diabetes mellitus and type 1 diabetes mellitus
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
While simultaneous pancreas kidney transplant (SPKTx) is a therapeutic option for patients with type 1 diabetes (T1DM) and renal failure, few centers offer SPKTx to â??selectâ?� non-T1DM patients. To address concerns that existing insulin resistance may limit the benefits of the pancreas allograft among non-T1DM we compared several indices of glucose homeostasis, in â??selectâ?�, non-T1DM and T1DM patients who received SPKTx. Criteria for â??selectâ?� non-T1DM included: Positive C-peptide, BMI <30 kg/m2, treatment with oral agents before insulin initiation and insulin at <1 unit/kg/day. We compared several indices of glucose homeostasis within 1 year post-SPKTx among seven â??selectâ?� patients with non-T1DM and nine patients with T1DM with similar age, BMI and immunosuppression. Measurements of insulin resistance included: Homeostatic model, insulin sensitivity index and insulin glucose ratio; insulin secretion measures included: Corrected insulin response. We found non-T1DM had similar pre-transplant metabolic (fasting glucose, HbA1C, blood pressure and lipid) parameters to the T1DM cohort. There were no significant differences in the various measures of insulin resistance and secretion between T1DM and â??selectâ?� non-T1DM patients. In conclusion our results suggest SPKTx should be considered in the therapeutic armamentarium among carefully select non-T1DM with features of minimal insulin resistance; however, a larger cohort with longer follow-up is needed to confirm our results.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Diabetes & Metabolism.
Rapid communication · 29 May 2025
Genetic and epigenetic markers for gdm risk
Short communication · 29 May 2025
Metabolic syndrome: Diet, timed eating, supplements
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Diabetes & Metabolism
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Harini A Chakkera”